Human macula formation involves two waves of retinoic acid suppression via CYP26A1 that modulate cell cycle exit and cone subtype specification
Stem Cell Reports · 2025-10 · 20 (10) · 102647
DOI: 10.1016/j.stemcr.2025.102647 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2025-10. Verfasst von Philippa Harding und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ocular Cell and Gene Therapy Group, Centre for Gene Therapy and Regenerative Medicine, King's College London, Tower Wing, Guy's Hospital, London SE1 …. Hauptthemen laut MEDLINE: Tretinoin, Retinoic Acid 4-Hydroxylase, Retinal Cone Photoreceptor Cells, Cell Cycle. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation Medical Research Council, Wellcome Trust, Fight for Sight.
Abstract (Originalsprache)
The human macula is a specialized, cone-rich region of the eye, critical for high-acuity vision, yet the pathways regulating its development remain poorly understood. RA-catabolizing enzyme CYP26A1 establishes the chick high-acuity area via upregulation of fibroblast growth factor 8 (FGF8). However, detailed analysis of this pathway and its functions has not been performed in early human fetal tissue. Fluorescent in situ hybridization revealed striking biphasic CYP26A1 expression but little FGF8 in the presumptive macula region between post-conception weeks (PCW) 6-17. Pharmacological retinoic acid (RA) signaling inhibition in human retinal organoids mimicking the two waves of CYP26A1 revealed early RA inhibition prompted early cell cycle exit and increased cone genesis, while late inhibition altered cone subtype specification. Conversely, recombinant FGF8 had no effect on photoreceptor fate. This work provides spatiotemporal examination of CYP26A1 across human macular development, as well as experimental evidence for the different roles of RA signaling inhibition in a human model of retinal development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ocular Cell and Gene Therapy Group, Centre for Gene Therapy and Regenerative Medicine, King's College London, Tower Wing, Guy's Hospital, London SE1 9RT, UK. Electronic address: philippa.harding@kcl.ac.uk.
- Ocular Cell and Gene Therapy Group, Centre for Gene Therapy and Regenerative Medicine, King's College London, Tower Wing, Guy's Hospital, London SE1 9RT, UK.
- Ocular Cell and Gene Therapy Group, Centre for Gene Therapy and Regenerative Medicine, King's College London, Tower Wing, Guy's Hospital, London SE1 9RT, UK. Electronic address: rachael.pearson@kcl.ac.uk.
Förderung
- UK Research and Innovation Medical Research Council
- Wellcome Trust
- Fight for Sight
Zitieren
APA
Harding, P., Wojtynska, M., Smith, A. J., Ali, R. R., & Pearson, R. A. (2025). Human macula formation involves two waves of retinoic acid suppression via CYP26A1 that modulate cell cycle exit and cone subtype specification. Stem Cell Reports, 20(10), 102647. https://doi.org/10.1016/j.stemcr.2025.102647
Vancouver
Harding P, Wojtynska M, Smith AJ, Ali RR, Pearson RA. Human macula formation involves two waves of retinoic acid suppression via CYP26A1 that modulate cell cycle exit and cone subtype specification. Stem Cell Reports. 2025;20(10):102647. doi:10.1016/j.stemcr.2025.102647
BibTeX
@article{Harding2025,
author = {Harding, Philippa and Wojtynska, Maja and Smith, Alexander J and Ali, Robin R and Pearson, Rachael A},
title = {Human macula formation involves two waves of retinoic acid suppression via CYP26A1 that modulate cell cycle exit and cone subtype specification},
journal = {Stem Cell Reports},
year = {2025},
volume = {20},
number = {10},
pages = {102647},
doi = {10.1016/j.stemcr.2025.102647}
}
EUVIMED